These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15611130)

  • 81. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.
    Han ES; Mekasha S; Ingalls RR
    J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
    Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
    J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
    Meijboom KE; Sutton ER; McCallion E; McFall E; Anthony D; Edwards B; Kubinski S; Tapken I; Bünermann I; Hazell G; Ahlskog N; Claus P; Davies KE; Kothary R; Wood MJA; Bowerman M
    Skelet Muscle; 2022 Jul; 12(1):18. PubMed ID: 35902978
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
    Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
    Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
    [TBL] [Abstract][Full Text] [Related]  

  • 85. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
    Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunohistochemical expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications.
    Acharya S; Prabhu P; Patil VS; Acharya AB; Nikhil K
    J Investig Clin Dent; 2019 Nov; 10(4):e12469. PubMed ID: 31541512
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
    De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
    Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Prigozhina TB; Szafer F; Aronin A; Tzdaka K; Amsili S; Makdasi E; Shani N; Dranitzki Elhalel M
    Cancer Lett; 2017 Aug; 400():99-109. PubMed ID: 28455246
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
    Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
    J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia.
    Vendrell J; Maymó-Masip E; Tinahones F; García-España A; Megia A; Caubet E; García-Fuentes E; Chacón MR
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2983-92. PubMed ID: 20382683
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TWEAK as a target for therapy in systemic lupus erythematosus.
    Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ
    Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-kappaB pathway.
    Brown SA; Ghosh A; Winkles JA
    J Biol Chem; 2010 Jun; 285(23):17432-41. PubMed ID: 20385556
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment.
    Zhou H; Ekmekcioglu S; Marks JW; Mohamedali KA; Asrani K; Phillips KK; Brown SA; Cheng E; Weiss MB; Hittelman WN; Tran NL; Yagita H; Winkles JA; Rosenblum MG
    J Invest Dermatol; 2013 Apr; 133(4):1052-62. PubMed ID: 23190886
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
    Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R; Bedi GC; Engstrom LW; Zeng Q; Mookerjee B; Gélinas C; Fuchs EJ; Bedi A
    Nat Cell Biol; 2001 Apr; 3(4):409-16. PubMed ID: 11283615
    [TBL] [Abstract][Full Text] [Related]  

  • 99. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.
    Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM
    PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.
    Tajrishi MM; Zheng TS; Burkly LC; Kumar A
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):215-25. PubMed ID: 24444596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.